In today’s era of intense public scrutiny on medical costs, what’s your pricing strategy? Does it pass the test of fairness and accuracy, without sacrificing revenue objectives? Panacea’s CEO, Frederick Stodolak, provides his recommendations on where to start.
https://insights.panaceainc.com/wp-content/uploads/2018/01/8_Article_PricingStrategies.jpg402604Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2020/02/logo-panacea-besler.pngPanacea Insights2020-07-01 08:11:122020-08-03 14:50:28Pricing Strategies. What’s Your Defense?
Coding and Billing Resources for Coronavirus COVID-19 Important information that provides current coding and billing updates from all of the regulatory agencies for our clients and the provider community during this public health emergency (PHE). We will continue to update this page as new guidance is received and reviewed by our senior healthcare consultants.
Panacea has summarized the Centers for Medicare and Medicaid Services (CMS) and American Medical Association (AMA) payment and coding updates, effective July 2020 (with some retroactive changes). Please review the updates for possible implementation in your hospital chargemaster and/or review by applicable department, coding and billing staff.
https://insights.panaceainc.com/wp-content/uploads/2020/06/healthcare-business-graph-and-medical-examination-and-businessman-picture-id1165046681.jpg400566Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2020/02/logo-panacea-besler.pngPanacea Insights2020-06-22 07:09:582020-09-20 10:45:57CMS and AMA payment and coding updates, effective July, 1 2020
As many of you have heard, there are major changes coming to evaluation and management (E&M) codes in 2021. The changes were finalized in the 2020 Physician Final Rule.
https://insights.panaceainc.com/wp-content/uploads/2019/12/closeup-shot-womans-they-consulting-and-meeting-with-tablet-computer-picture-id1193042741.jpg400566Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2020/02/logo-panacea-besler.pngPanacea Insights2020-06-17 12:12:282020-06-25 15:50:12E&M Changes: How Will They Affect Your Practice?
Compliance plans are critical to making sure your organization is mitigating risk. The Office of Inspector General (OIG) recommends that you audit a minimum of 10 professional encounters per year per physician—but if you’re not going above and beyond that by performing focused audits, you’re putting your practice at risk by ignoring everything else. Not […]
Telehealth Expansion for Hospitals CMS is increasing access to telehealth for Medicare patients. What this means for hospitals is they will be permitted to code and bill during the PHE for services to which allowed physicians and practitioners employed by the hospital perform a face-to-face visit via telehealth service for a registered outpatient of the […]
The radiology department is typically one of the biggest within a healthcare facility, and the Radiology Information System (RIS) is a critical component of this department. Facilities rely on these systems to manage imaging protocols by modality as well as charging for services and orderables. Therefore, if your RIS contains incorrect or outdated data, you […]
https://insights.panaceainc.com/wp-content/uploads/2020/05/RIS-article-Insights-Post.jpg400566Panacea Insightshttps://insights.panaceainc.com/wp-content/uploads/2020/02/logo-panacea-besler.pngPanacea Insights2020-05-28 08:21:562020-07-01 13:00:54Maintaining the Health of Your Radiology Information System (RIS)
Please join us on Thursday, June 4, 2020, at 1 pm ET, for our 90-minute live webinar, “How to Avoid the 5 Pitfalls In Coding Nuclear Medicine, Diagnostic Radiology, and Interventional Services.” The webinar will focus on learning how to avoid coding and compliance risks and how to capture all charges for Nuclear Medicine and […]
In the CMS-5531-IFC dated April 30, 2020, CMS has stated COVID-19 serology antibody testing will be coverable by the Medicare program because they fall under at least one Medicare benefit category. The serology test that detects antibodies to SARS-CoV-2, the virus that causes COVD-19, may potentially aid in identifying patients who have had an immune […]